Antibodies
Bi-specifics
ADC's
Nanobodies
Fab Fragments
Cell
Based Therapies
PEGylated proteins
Oligonucleotides
Our methods have been successfully applied in global pharmaceutical companies with tangible results including patents. We have the unique tested expertise developing bi-specifics, antibody-drug conjugates, scFv’s, nanobodies, cell based therapies to provide tailored support for your program.